Association between vitamin D deficiency and methicillin-resistant Staphylococcus aureus infection

Infection

Volumn 43, Issue 6, 2015, Pages 715-722

  Thomason, Jenna ^a   Rentsch, Christopher ^b   Stenehjem, Edward A ^c   Hidron, Alicia I ^d   Rimland, David ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTERMOUNTAIN MEDICAL CENTER   (United States)

^d UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

Author keywords

MRSA infection; Staphyloccoccus aureus; Veteran population; Vitamin D deficiency

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PROSPECTIVE STUDY; VITAMIN D DEFICIENCY; COMPLICATION; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VITAMIN D DEFICIENCY;

EID: 84947923636     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-015-0815-5     Document Type: Article

References (27)

1. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res. 2011;55:96–108.
2. Panierakis C, Goulielmos G, Mamoulakis D, Maraki S, Papavasiliou E, Galanakis E. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes. Int J Infect Dis. 2009;13:e437–43.
3. Claassen M, Nouwen J, Fang Y, Ott A, Verbrugh H, Hofman A, van Belkum A, Uitterlinden A. Staphylococcus aureus nasal carriage is not associated with known polymorphism in the vitamin D receptor gene. FEMS Immunol Med Microbiol. 2005;43:173–6.
4. Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, Grimnes G, Jorde R, Simonsen GS, Furberg AS. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study. Eur J Clin Microbiol Infect Dis. 2012;31:465–73.
5. Slow S, Priest PC, Chambers ST, Stewart AW, Jennings LC, Florkowski CM, Livesey JH, Camargo CA Jr, Scragg R, Murdoch DR. Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: a randomized, double-blind, placebo-controlled trial in healthy adults. Clin Microbiol Infect. 2014;20(5):453–8.
6. Matheson EM, Mainous AG 3rd, Hueston WJ, Diaz VA, Everett CJ. Vitamin D and methicillin resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis. 2010;42:455–60.
7. Jevons MP. “Celbenin”-resistant staphylococci. Br Med J. 1961;2:124–33.
8. Maple PA, Hamilton-Miller JM, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1989;1:537–40.
9. Martin MA. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis. 1994;14:170–91.
10. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005;5:275–86.
11. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874–85.
12. Krishna S, Miller LS. Innate and adaptive immune responses against Staphylococcusaureus skin infections. Semin Immunopathol. 2011.
13. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;1:S344–9.
14. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011.
15. Stenehjem E, Stafford C, Rimland D. Reduction of methicillin-resistant. Staphylococcus aureus infection among veterans in Atlanta. Infect Control Hosp Epidemiol. 2013;34:62–8.
16. Major JM, Graubard BI, Dodd KW, Iwan A, Alexander BH, Linet MS, Freedman DM. Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. J Clin Endocrinol Metab. 2013;98:97–104.
17. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. M100-S21. Wayne: Clinical and Laboratory Standards Institute, 2011. http://www.clsi.org/source/orders/free/m100-s21.pdf. Accessed 20 Dec 2010.
18. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health. Care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.
19. Komatsuzawa H, Ouhara K, Yamada S, Fujiwara T, Sayama K, Hashimoto K, Sugai M. Innate defences against methicillin-resistant Staphylococcus aureus (MRSA) infection. J Pathol. 2006;208:249–60.
20. Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013;66:620–2.
21. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK. Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–71.
22. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS. 2007;18:521–6.
23. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88:558S–64S.
24. Hidron A, Moanna A, Rimland D. The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients. AIDS. 2011;25:1001–9.
25. Caffrey AR, LaPlante KL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in the Veterans Affairs Healthcare System, 2002–2009. Infection. 2012;40:291–7.
26. Youssef D, Bailey B, El Abbassi A, Copeland R, Adebonojo L, Manning T, Peiris AN. Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect. 2010;138:1322–7.
27. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract. 2009;15:438–49.